GGrantIndex
← Leaderboards

Simon W John

Columbia University Health Sciences

$17,840,585
Attributed
$20,699,392
Total exposure
5
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$20,699,392 · 5

By mechanism

R01$20,472,452 · 4
R29$226,940 · 1

Top collaborators

Most similar at Columbia University Health Sciences

Same institution · by research overlap

Others in their field

Top investigators on “Glaucoma

Research focus

GlaucomaMolecularPathway InteractionsGenesHigh Intraocular PressureRisk FactorsDrainage ProcedureMutantPhysiologic Intraocular PressureStructureMutant Strains MiceGeneticComplexResistanceMutagenesisCollectionBlindnessCommunitiesGenomicsPhenotypeInduced MutationMutationInheritedCell Death

Grant awards (34)

Does VECAD at Schlemm canal cell-junctions determine IOP and glaucoma risk?$705,235
R01 · FY2025 · EY · contact PI
Does VECAD at Schlemm canal cell-junctions determine IOP and glaucoma risk?$711,715
R01 · FY2024 · EY · contact PI
Models, mechanisms and treatment of LMX1B-induced glaucoma$590,041
R01 · FY2024 · EY · contact PI
Does VECAD at Schlemm canal cell-junctions determine IOP and glaucoma risk?$711,715
R01 · FY2023 · EY · contact PI
Models, mechanisms and treatment of LMX1B-induced glaucoma$590,041
R01 · FY2023 · EY · contact PI
Cell Death Pathways in Glaucomatous Neurodegeneration$570,843
R01 · FY2023 · EY
Does VECAD at Schlemm canal cell-junctions determine IOP and glaucoma risk?$698,220
R01 · FY2022 · EY · contact PI
Models, mechanisms and treatment of LMX1B-induced glaucoma$572,340
R01 · FY2022 · EY · contact PI
Cell Death Pathways in Glaucomatous Neurodegeneration$553,716
R01 · FY2022 · EY
Does VECAD at Schlemm canal cell-junctions determine IOP and glaucoma risk?$672,790
R01 · FY2021 · EY · contact PI
Models, mechanisms and treatment of LMX1B-induced glaucoma$587,611
R01 · FY2021 · EY · contact PI
Cell Death Pathways in Glaucomatous Neurodegeneration$553,716
R01 · FY2021 · EY
Cell Death Pathways in Glaucomatous Neurodegeneration$539,665
R01 · FY2020 · EY
Factors Determining Intraocular Pressure and Glaucoma Susceptibility$636,870
R01 · FY2018 · EY · contact PI
Factors Determining Intraocular Pressure and Glaucoma Susceptibility$150,130
R01 · FY2018 · EY · contact PI
Factors Determining Intraocular Pressure and Glaucoma Susceptibility$787,000
R01 · FY2017 · EY · contact PI
Factors Determining Intraocular Pressure and Glaucoma Susceptibility$787,000
R01 · FY2016 · EY · contact PI
Factors Determining Intraocular Pressure and Glaucoma Susceptibility$771,258
R01 · FY2015 · EY · contact PI
Factors Determining Intraocular Pressure and Glaucoma Susceptibility$787,000
R01 · FY2014 · EY · contact PI
Factors Determining Intraocular Pressure$248,500
R01 · FY2012 · EY · contact PI
Factors Determining Intraocular Pressure$746,305
R01 · FY2011 · EY · contact PI
Factors Determining Intraocular Pressure$754,759
R01 · FY2010 · EY · contact PI
Factors Determining Intraocular Pressure$758,553
R01 · FY2009 · EY · contact PI
Factors Determining Intraocular Pressure$740,175
R01 · FY2009 · EY · contact PI
Factors Determining Intraocular Pressure$704,247
R01 · FY2008 · EY · contact PI
Factors Determining Intraocular Pressure$299,976
R01 · FY2008 · EY · contact PI
Factors Determining Intraocular Pressure$696,344
R01 · FY2007 · EY · contact PI
Factors Determining Intraocular Pressure$743,948
R01 · FY2006 · EY · contact PI
Factors Determining Intraocular Pressure$739,661
R01 · FY2005 · EY
Factors Determining Intraocular Pressure$718,118
R01 · FY2004 · EY
Factors Determining Intraocular Pressure$697,202
R01 · FY2003 · EY
Factors Determining Intraocular Pressure$647,758
R01 · FY2002 · EY
FACTORS DETERMINING INTRAOCULAR PRESSURE$113,470
R29 · FY2001 · EY
FACTORS DETERMINING INTRAOCULAR PRESSURE$113,470
R29 · FY2000 · EY